Destiny Pharma PLC unveils further positive results for c-difficile treatment as market research points to its commercial potential
NTCD-M3, which researchers are readying to phase III scientific trials, was the subject matter to
treatment
CMS proposes limiting Medicare coverage for the treatment of Alzheimer’s to clinical trials
Image: FatCamera/Getty Photos The Centers for Medicare and Medicaid Services has released a proposed Countrywide
Destiny Pharma PLC making significant strides towards phase III evaluation of potential breakthrough C.diff treatment
CEO Neil Clark reported: “We have created important progress due to the fact closing the
CMS issues billing codes for Eli Lilly’s COVID-19 antibody treatment
The Centers for Medicare and Medicaid Providers has released billing codes for Eli Lilly’s COVID-19
Eli Lilly and UnitedHealth Group partner on COVID-19 antibody treatment for high-risk individuals
UnitedHealth Group is partnering with Eli Lilly to exam the efficacy of its COVID-19 monoclonal
The UK’s Hartree Centre deploys Atos supercomputer for Coronavirus treatment research
### About Atos Atos is a worldwide chief in electronic transformation with in excess of
New treatment to slow muscle wastag… – Information Centre – Research & Innovation
A drugs developed by EU-funded researchers has been approved to treat young children with the
Highmark launches technology-enabled opioid treatment program in West Virginia
Highmark West Virginia is providing its customers access to a technological know-how-enabled opioid use dysfunction